The role of bariatric surgery to treat diabetes: current challenges and perspectives.

作者: Chrysi Koliaki , Stavros Liatis , Carel W. le Roux , Alexander Kokkinos

DOI: 10.1186/S12902-017-0202-6

关键词: ObesityGlycemicIncretinMedicineDiabetes mellitusType 2 Diabetes MellitusSurgerySleeve gastrectomyWeight lossClass I obesity

摘要: Bariatric surgery is emerging as a powerful weapon against severe obesity and type 2 diabetes mellitus (T2DM). Given its role in metabolic regulation, the gastrointestinal tract constitutes meaningful target to treat T2DM, especially light of accumulating evidence that with manipulations may result T2DM remission (metabolic surgery). The major mechanisms mediating weight loss-independent effects bariatric comprise on tissue-specific insulin sensitivity, β-cell function incretin responses, changes bile acid composition flow, modifications gut microbiota, intestinal glucose metabolism increased brown adipose tissue activity. Shorter duration, better preoperative glycemic control profound loss, have been associated higher rates lower risk relapse. In short medium term, significant amount lost, completely regress, cardiometabolic factors are dramatically improved. long achieve durable prevent cancer, improve overall while leading remission, reduce total cause-specific mortality. gradient efficacy for loss comparing four established surgical procedures biliopancreatic diversion >Roux-en-Y gastric bypass >sleeve gastrectomy >laparoscopic adjustable banding. According recently released guidelines, should be recommended diabetic patients class III obesity, regardless their level control, II inadequately controlled despite lifestyle optimal medical therapy. Surgery also considered I hyperglycemia treatment.

参考文章(55)
John M. Wentworth, Julie Playfair, Cheryl Laurie, Wendy A. Brown, Paul Burton, Jonathan E. Shaw, Paul E. O’Brien, Gastric Band Surgery Leads to Improved Insulin Secretion in Overweight People with Type 2 Diabetes Obesity Surgery. ,vol. 25, pp. 2400- 2407 ,(2015) , 10.1007/S11695-015-1716-5
Geltrude Mingrone, Simona Panunzi, Andrea De Gaetano, Caterina Guidone, Amerigo Iaconelli, Giuseppe Nanni, Marco Castagneto, Stefan Bornstein, Francesco Rubino, Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial The Lancet. ,vol. 386, pp. 964- 973 ,(2015) , 10.1016/S0140-6736(15)00075-6
Lars Sjöström, Markku Peltonen, Peter Jacobson, Sofie Ahlin, Johanna Andersson-Assarsson, Åsa Anveden, Claude Bouchard, Björn Carlsson, Kristjan Karason, Hans Lönroth, Ingmar Näslund, Elisabeth Sjöström, Magdalena Taube, Hans Wedel, Per-Arne Svensson, Kajsa Sjöholm, Lena M. S. Carlsson, Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications JAMA. ,vol. 311, pp. 2297- 2304 ,(2014) , 10.1001/JAMA.2014.5988
David E. Arterburn, Andy Bogart, Nancy E. Sherwood, Stephen Sidney, Karen J. Coleman, Sebastien Haneuse, Patrick J. O’Connor, Mary Kay Theis, Guilherme M. Campos, David McCulloch, Joe Selby, A Multisite Study of Long-term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass Obesity Surgery. ,vol. 23, pp. 93- 102 ,(2013) , 10.1007/S11695-012-0802-1
Florencia Halperin, Su-Ann Ding, Donald C. Simonson, Jennifer Panosian, Ann Goebel-Fabbri, Marlene Wewalka, Osama Hamdy, Martin Abrahamson, Kerri Clancy, Kathleen Foster, David Lautz, Ashley Vernon, Allison B. Goldfine, Roux-en-Y Gastric Bypass Surgery or Lifestyle With Intensive Medical Management in Patients With Type 2 Diabetes: Feasibility and 1-Year Results of a Randomized Clinical Trial JAMA Surgery. ,vol. 149, pp. 716- 726 ,(2014) , 10.1001/JAMASURG.2014.514
Robert C. Pendleton, Michael B. Strong, Russell Vinik, Nathan A. Wanner, Paul N. Hopkins, Richard E. Gress, James M. Walker, Tom V. Cloward, R. Tom Nuttall, Ahmad Hammoud, Jessica L. J. Greenwood, Ross D. Crosby, Rodrick McKinlay, Steven C. Simper, Sherman C. Smith, Steven C. Hunt, Ted D. Adams, Lance E. Davidson, Sheldon E. Litwin, Ronette L. Kolotkin, Michael J. LaMonte, Health Benefits of Gastric Bypass Surgery after 6 Years JAMA. ,vol. 308, pp. 1122- 1131 ,(2012) , 10.1001/2012.JAMA.11164
Haoyong Yu, Jianzhong Di, Yuqian Bao, Pin Zhang, Lei Zhang, Yinfang Tu, Xiaodong Han, Weiping Jia, Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2 Surgery for Obesity and Related Diseases. ,vol. 11, pp. 6- 11 ,(2015) , 10.1016/J.SOARD.2014.06.019
John B. Dixon, Paul E. O’Brien, Julie Playfair, Leon Chapman, Linda M. Schachter, Stewart Skinner, Joseph Proietto, Michael Bailey, Margaret Anderson, Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes JAMA. ,vol. 299, pp. 316- 323 ,(2008) , 10.1001/JAMA.299.3.316
David E. Arterburn, Maren K. Olsen, Valerie A. Smith, Edward H. Livingston, Lynn Van Scoyoc, William S. Yancy, George Eid, Hollis Weidenbacher, Matthew L. Maciejewski, Association Between Bariatric Surgery and Long-term Survival JAMA. ,vol. 313, pp. 62- 70 ,(2015) , 10.1001/JAMA.2014.16968